ArticleMedical oncology (Northwood, London, England)2022

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.

Shazia Sofi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.